637 related articles for article (PubMed ID: 18063411)
1. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
[TBL] [Abstract][Full Text] [Related]
2. Change in lateralization of the P22/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A.
Kanovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
Mov Disord; 1998 Jan; 13(1):108-17. PubMed ID: 9452335
[TBL] [Abstract][Full Text] [Related]
3. Cervical dystonia affects aimed movements of nondystonic segments.
Pelosin E; Bove M; Marinelli L; Abbruzzese G; Ghilardi MF
Mov Disord; 2009 Oct; 24(13):1955-61. PubMed ID: 19609907
[TBL] [Abstract][Full Text] [Related]
4. Comparison of treatment of tardive dystonia and idiopathic cervical dystonia with botulinum toxin type A.
Brashear A; Ambrosius WT; Eckert GJ; Siemers ER
Mov Disord; 1998 Jan; 13(1):158-61. PubMed ID: 9452343
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.
Slawek J; Friedman A; Potulska A; Krystkowiak P; Gervais C; Banach M; Ochudlo S; Budrewicz S; Reclawowicz D; Rynkowski M; Opala G
Funct Neurol; 2007; 22(2):95-100. PubMed ID: 17637212
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin and neuromotor rehabilitation: An integrated approach to idiopathic cervical dystonia.
Tassorelli C; Mancini F; Balloni L; Pacchetti C; Sandrini G; Nappi G; Martignoni E
Mov Disord; 2006 Dec; 21(12):2240-3. PubMed ID: 17029278
[TBL] [Abstract][Full Text] [Related]
7. Reverse sensory geste in cervical dystonia.
Asmus F; von Coelln R; Boertlein A; Gasser T; Mueller J
Mov Disord; 2009 Jan; 24(2):297-300. PubMed ID: 19086084
[TBL] [Abstract][Full Text] [Related]
8. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor.
Wissel J; Masuhr F; Schelosky L; Ebersbach G; Poewe W
Mov Disord; 1997 Sep; 12(5):722-6. PubMed ID: 9380055
[TBL] [Abstract][Full Text] [Related]
9. Clinical changes of cervical dystonia pattern in long-term botulinum toxin treated patients.
Maia FM; Kanashiro AK; Chien HF; Gonçalves LR; Barbosa ER
Parkinsonism Relat Disord; 2010 Jan; 16(1):8-11. PubMed ID: 19589716
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
[TBL] [Abstract][Full Text] [Related]
11. Somatosensory temporal discrimination tested in patients receiving botulinum toxin injection for cervical dystonia.
Scontrini A; Conte A; Fabbrini G; Colosimo C; Di Stasio F; Ferrazzano G; Berardelli A
Mov Disord; 2011 Mar; 26(4):742-6. PubMed ID: 21506155
[TBL] [Abstract][Full Text] [Related]
12. The utility of EMG interference pattern analysis in botulinum toxin treatment of torticollis: a randomised, controlled and blinded study.
Werdelin L; Dalager T; Fuglsang-Frederiksen A; Regeur L; Karlsborg M; Korbo L; Munck O; Winge K
Clin Neurophysiol; 2011 Nov; 122(11):2305-9. PubMed ID: 21636319
[TBL] [Abstract][Full Text] [Related]
13. Neck movement speed in cervical dystonia.
De Beyl DZ; Salvia P
Mov Disord; 2009 Nov; 24(15):2267-71. PubMed ID: 19845012
[TBL] [Abstract][Full Text] [Related]
14. Variability of the immunologic and clinical response in dystonic patients immunoresistant to botulinum toxin injections.
Sankhla C; Jankovic J; Duane D
Mov Disord; 1998 Jan; 13(1):150-4. PubMed ID: 9452341
[TBL] [Abstract][Full Text] [Related]
15. Use of botulinum toxin type A in the treatment of cervical dystonia.
Comella CL; Jankovic J; Brin MF
Neurology; 2000; 55(12 Suppl 5):S15-21. PubMed ID: 11188979
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia.
Factor SA; Molho ES; Evans S; Feustel PJ
Mov Disord; 2005 Sep; 20(9):1152-60. PubMed ID: 15954134
[TBL] [Abstract][Full Text] [Related]
17. Headache in cranial and cervical dystonia.
Barbanti P; Fabbrini G; Pauletti C; Defazio G; Cruccu G; Berardelli A
Neurology; 2005 Apr; 64(7):1308-9. PubMed ID: 15824376
[No Abstract] [Full Text] [Related]
18. Long-term botulinum toxin efficacy, safety, and immunogenicity.
Mejia NI; Vuong KD; Jankovic J
Mov Disord; 2005 May; 20(5):592-7. PubMed ID: 15645481
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments.
Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O
Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708
[TBL] [Abstract][Full Text] [Related]
20. The position of the head in space: a kinematic analysis in patients with cervical dystonia treated with botulinum toxin.
Albani G; Bulgheroni MV; Mancini F; Mauro A; Fundarò C; Pacchetti C; Sandrini G; Nappi G
Funct Neurol; 2001; 16(2):135-41. PubMed ID: 11495419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
